Cargando…

Pterostilbene Reduces Liver Steatosis and Modifies Hepatic Fatty Acid Profile in Obese Rats

Excessive fat accumulation within the liver is known as “simple hepatic steatosis”, which is the most benign form of non-alcoholic fatty liver disease (NAFLD). The aim of the present study was to determine whether pterostilbene improves this hepatic alteration in Zucker (fa/fa) rats. Animals were di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aguirre, Leixuri, Palacios-Ortega, Sara, Fernández-Quintela, Alfredo, Hijona, Elizabeth, Bujanda, Luis, Portillo, María P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566509/ https://www.ncbi.nlm.nih.gov/pubmed/31035507 http://dx.doi.org/10.3390/nu11050961

Ejemplares similares

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Lack of Additive Effects of Resveratrol and Energy Restriction in the Treatment of Hepatic Steatosis in Rats
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2017)

Resveratrol: Anti-Obesity Mechanisms of Action
por: Aguirre, Leixuri, et al.
Publicado: (2014)

Activity of Pterostilbene Metabolites against Liver Steatosis in Cultured Hepatocytes
por: Trepiana, Jenifer, et al.
Publicado: (2020)

Relationship between Changes in Microbiota and Liver Steatosis Induced by High-Fat Feeding—A Review of Rodent Models
por: Gómez-Zorita, Saioa, et al.
Publicado: (2019)

Comparative Effects of Pterostilbene and Its Parent Compound Resveratrol on Oxidative Stress and Inflammation in Steatohepatitis Induced by High-Fat High-Fructose Feeding
por: Gómez-Zorita, Saioa, et al.
Publicado: (2020)

Anti-Obesity Effects of Macroalgae
por: Gómez-Zorita, Saioa, et al.
Publicado: (2020)

Anti-Obesity Effects of Microalgae
por: Gómez-Zorita, Saioa, et al.
Publicado: (2019)

Resveratrol and Pterostilbene, Two Analogue Phenolic Compounds, Affect Aquaglyceroporin Expression in a Different Manner in Adipose Tissue
por: Gómez-Zorita, Saioa, et al.
Publicado: (2018)

Resveratrol-Induced Effects on Body Fat Differ Depending on Feeding Conditions
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2017)

Effect of Microalgae and Macroalgae Extracts on Non-Alcoholic Fatty Liver Disease
por: González-Arceo, Maitane, et al.
Publicado: (2021)

Novel equation to determine the hepatic triglyceride concentration in humans by MRI: diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery
por: Jiménez-Agüero, Raúl, et al.
Publicado: (2014)

Gut Microbiota Induced by Pterostilbene and Resveratrol in High-Fat-High-Fructose Fed Rats: Putative Role in Steatohepatitis Onset
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2021)

Involvement of 5′AMP-Activated Protein Kinase (AMPK) in the Effects of Resveratrol on Liver Steatosis
por: Trepiana, Jenifer, et al.
Publicado: (2018)

Are miRNA-103, miRNA-107 and miRNA-122 Involved in the Prevention of Liver Steatosis Induced by Resveratrol?
por: Gracia, Ana, et al.
Publicado: (2017)

OR27-2 Growth Hormone Reduces Hepatic Steatosis, Inflammation and Fibrosis in Adults with Overweight/Obesity and Nonalcoholic Fatty Liver Disease
por: Bartsch, Lea, et al.
Publicado: (2022)

Metabolomic Phenotype of Hepatic Steatosis and Fibrosis in Mexican Children Living with Obesity
por: Garibay-Nieto, Nayely, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease: molecular mechanisms for the hepatic steatosis
por: Koo, Seung-Hoi
Publicado: (2013)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Consumption of Spinach and Tomato Modifies Lipid Metabolism, Reducing Hepatic Steatosis in Rats
por: Elvira-Torales, Laura Inés, et al.
Publicado: (2020)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?
por: McNelis, Kera, et al.
Publicado: (2021)

Resveratrol inhibits nonalcoholic fatty liver disease in rats
por: Bujanda, Luis, et al.
Publicado: (2008)

Targeting peroxisomal fatty acid oxidation improves hepatic steatosis and insulin resistance in obese mice
por: Yao, Haoya, et al.
Publicado: (2022)

Pterostilbene in Cancer Therapy
por: Obrador, Elena, et al.
Publicado: (2021)

Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis
por: Lee, Hyo Young, et al.
Publicado: (2019)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
por: Li, Jinwang, et al.
Publicado: (2021)

Liquid Biopsy for the Diagnosis of Viral Hepatitis, Fatty Liver Steatosis, and Alcoholic Liver Diseases
por: Shabangu, Ciniso Sylvester, et al.
Publicado: (2020)

Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
por: Luukkonen, Panu K., et al.
Publicado: (2020)

Hepatic Steatosis Index in the Detection of Fatty Liver in Patients with Chronic Hepatitis B Receiving Antiviral Therapy
por: Chang, Jin Won, et al.
Publicado: (2021)

Metabolic Consequences of Hepatic Steatosis in Overweight and Obese Adolescents
por: Wicklow, Brandy A., et al.
Publicado: (2012)

Nutritional Approaches in Children with Overweight or Obesity and Hepatic Steatosis
por: Spiezia, Chiara, et al.
Publicado: (2023)

Do the Effects of Resveratrol on Thermogenic and Oxidative Capacities in IBAT and Skeletal Muscle Depend on Feeding Conditions?
por: Milton-Laskibar, Iñaki, et al.
Publicado: (2018)

The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population
por: Bedogni, Giorgio, et al.
Publicado: (2006)

Lipopolysaccharides accelerate hepatic steatosis in the development of nonalcoholic fatty liver disease in Zucker rats
por: Fukunishi, Shinya, et al.
Publicado: (2014)

Differing Associations between Fatty Liver and Dyslipidemia According to the Degree of Hepatic Steatosis in Korea
por: Han, Ji Min, et al.
Publicado: (2019)

Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease
por: Pirmoazen, Amir M., et al.
Publicado: (2020)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease
por: Liu, Chang-Hai, et al.
Publicado: (2022)

Change in skeletal muscle mass is associated with hepatic steatosis in nonalcoholic fatty liver disease
por: Jo, Ik Hyun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_icolmm7akcvcukcbvvq0j4s1dv